Skip to content

Total debt at other companies

The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
$104.95M+2.5%
Astrana Health logo
Astrana HealthASTH
$1.07B+136%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$2.7B-0.6%
CVS Health logo
CVS HealthCVS
UnitedHealth Group logo
UnitedHealth GroupUNH
Elevance Health logo
Elevance HealthELV

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Calculated from Evolent Health, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s total debt?
Evolent Health, Inc. (EVH) reported total debt of $985.43M in Q1 2026.
How has Evolent Health, Inc.'s total debt changed year-over-year?
Evolent Health, Inc.'s total debt increased by 13.3% year-over-year, from $870.1M to $985.43M.
What is the long-term trend for Evolent Health, Inc.'s total debt?
Over 5 years (2020 to 2025), Evolent Health, Inc.'s total debt has grown at a 22.4% compound annual growth rate (CAGR), from $359.78M to $989.7M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.